EUVIMEDEUVIMED entdecken
Open Access

RNF216 as a Promising Biomarker for Prognosis, Immunotherapy, and Chemotherapy in LIHC: A Comprehensive Pan-Cancer Analysis and Experimental Validation

Ke Du, Xiao Liang, Bowen Qin, Zitao Liu, Nanbin Liu, Pincheng Li, Qian Wang, Yajie Qi, Enze Shi, Kun Li

Journal of Cancer · 30.01.2026 · 17 (3) · 483-506

DOI: 10.7150/jca.125407 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cancer, erschienen am 30.01.2026. Verfasst von Ke Du und 9 weiteren Autor:innen. Beteiligte Einrichtung: National and Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'…. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

LIHCRNF216chemotherapyimmunotherapyprognosis

Autor:innen und Institutionen

  • National and Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.

Zitieren

APA

Du, K., Liang, X., Qin, B., Liu, Z., Liu, N., Li, P., Wang, Q., Qi, Y., Shi, E., & Li, K. (2026). RNF216 as a Promising Biomarker for Prognosis, Immunotherapy, and Chemotherapy in LIHC: A Comprehensive Pan-Cancer Analysis and Experimental Validation. Journal of Cancer, 17(3), 483-506. https://doi.org/10.7150/jca.125407

Vancouver

Du K, Liang X, Qin B, Liu Z, Liu N, Li P, et al. RNF216 as a Promising Biomarker for Prognosis, Immunotherapy, and Chemotherapy in LIHC: A Comprehensive Pan-Cancer Analysis and Experimental Validation. Journal of Cancer. 2026;17(3):483-506. doi:10.7150/jca.125407

BibTeX
@article{Du2026,
  author = {Du, Ke and Liang, Xiao and Qin, Bowen and Liu, Zitao and Liu, Nanbin and Li, Pincheng and Wang, Qian and Qi, Yajie and Shi, Enze and Li, Kun},
  title = {RNF216 as a Promising Biomarker for Prognosis, Immunotherapy, and Chemotherapy in LIHC: A Comprehensive Pan-Cancer Analysis and Experimental Validation},
  journal = {Journal of Cancer},
  year = {2026},
  volume = {17},
  number = {3},
  pages = {483--506},
  doi = {10.7150/jca.125407}
}
Kostenlos starten →